进展性肌肉松在性结肠炎的有效性:一个随机对照试验
Yağmur Artan1, Yasemin Yıldırım2, Nalan Gülşen Ünal3
1Faculty of Health Sciences, Nursing Department, Ardahan University, Ardahan, Turkey.
International journal of nursing practice
|October 7, 2025
概括
渐进性肌肉松显著改善了性结肠炎患者的生活质量,焦虑和睡眠质量. 这种可访问的护理干预提供了一种有价值的方法来管理患者的福祉.
科学领域:
- 胃肠病学 胃肠病学
- 心理神经免疫学 心理神经免疫学
- 护理研究 护理研究
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病,影响患者的心理和功能状态.
- 目前的管理往往侧重于疾病活动,不太重视整体的患者福祉.
- 探索非药物干预措施对于改善UC患者的生活质量至关重要.
研究的目的:
- 评估渐进性肌肉松 (PMR) 对性结肠炎患者的疾病活动,焦虑,睡眠质量和生活质量的影响.
- 将PMR与放松音乐和标准护理进行比较,以管理UC患者的治疗结果.
- 确定PMR作为UC的护理干预措施的有效性.
主要方法:
- 一项随机的,评估者盲目的,三臂研究,涉及60名性结肠炎患者.
- 患者被分配到渐进性肌肉放松,放松音乐或标准护理组,持续8周.
- 包括疾病活性,焦虑,睡眠质量和生活质量在内的结果使用经过验证的仪器进行了评估.
主要成果:
- 与其他组相比,渐进性肌肉放松组在生活质量,焦虑程度和睡眠质量方面表现出显著的改善.
- 在渐进肌肉放松,放松音乐和标准护理组之间没有观察到疾病活动的统计学上显著差异.
- 在性结肠炎患者中,PMR与改善心理和功能结果有关.
结论:
- 渐进性肌肉放松是一种有效的,负担得起的,易于实施的护理干预措施,用于改善性结肠炎患者的心理和功能结果.
- PMR为标准护理提供了一种有价值的非药物补充,以提高患者的福祉.
- 进一步的研究可能会探索PMR的长期影响及其对UC疾病活动标志物的影响.
相关概念视频
01:09Peripherally and Centrally Acting Muscle Relaxants: A Comparison
4.5K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
4.5K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
456
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
456
01:21Drugs for Treatment of Constipation-Predominant IBS
717
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
717
01:17Drugs for Treatment of Diarrhea-Predominant IBS
631
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
631
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
641
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
641
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
637
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
637